Is It Finally Time to Buy Gilead Sciences?
Gilead Sciences makes most of its money marketing HIV drugs, and it's launched a slate of new HIV therapies that are helping increase HIV revenue.
|
View article...
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.
Gilead Sciences makes most of its money marketing HIV drugs, and it's launched a slate of new HIV therapies that are helping increase HIV revenue.
|